コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 equently mutated in Moyamoya disease, a rare cerebrovascular disorder.
2 on 3 (CCM3) results in an autosomal dominant cerebrovascular disorder.
3 eral autosomal dominantly inherited forms of cerebrovascular disorders.
4 activity may hold therapeutic potential for cerebrovascular disorders.
5 iated with underlying hereditary or acquired cerebrovascular disorders.
6 sformed diagnosis, therapy, and prognosis of cerebrovascular disorders.
7 71-0.77)], heart failure [0.74 (0.70-0.77)], cerebrovascular disorders [0.76 (0.74-0.78)], ischaemic
8 c embolism (4.8; 95% CI, 2.9-7.8), puerperal cerebrovascular disorders (4.7; 95% CI, 3.0-7.4), and bl
10 e combination of keywords Alzheimer disease, cerebrovascular disorders, and drug therapy, and the com
11 drinking, ethanol, cerebrovascular accident, cerebrovascular disorders, and intracranial embolism and
12 rieved using MEDLINE (search terms, aspirin, cerebrovascular disorders, and stroke), bibliographies o
13 ering analysis identified factors related to cerebrovascular disorders, as well as diagnoses which in
14 he measurement of CBF has obvious utility in cerebrovascular disorders, because CBF is closely couple
16 complications, major adverse cardiac events, cerebrovascular disorders, dysrhythmia, ischemic heart d
17 sease spanning several categories, including cerebrovascular disorders, dysrhythmias, ischemic and no
18 Major changes in the treatment of various cerebrovascular disorders have occurred with improvement
19 e report on 3 babies with different neonatal cerebrovascular disorders including ischemic infarction
20 t the genotypes, genetic characterization of cerebrovascular disorders is valuable for understanding
21 ias, inflammatory heart disease, thrombosis, cerebrovascular disorders, ischemic heart disease and ot
22 y factor for Moyamoya disease, a progressive cerebrovascular disorder that often leads to brain strok